1169 related articles for article (PubMed ID: 31783383)
1. Multifunctional theranostic agents based on prussian blue nanoparticles for tumor targeted and MRI-guided photodynamic/photothermal combined treatment.
Lin X; Cao Y; Xue Y; Wu F; Yu F; Wu M; Zhu X
Nanotechnology; 2020 Mar; 31(13):135101. PubMed ID: 31783383
[TBL] [Abstract][Full Text] [Related]
2. Light-activatable Chlorin e6 (Ce6)-imbedded erythrocyte membrane vesicles camouflaged Prussian blue nanoparticles for synergistic photothermal and photodynamic therapies of cancer.
Sun L; Li Q; Hou M; Gao Y; Yang R; Zhang L; Xu Z; Kang Y; Xue P
Biomater Sci; 2018 Oct; 6(11):2881-2895. PubMed ID: 30192355
[TBL] [Abstract][Full Text] [Related]
3. Chlorin e6 and polydopamine modified gold nanoflowers for combined photothermal and photodynamic therapy.
Wu F; Liu Y; Wu Y; Song D; Qian J; Zhu B
J Mater Chem B; 2020 Mar; 8(10):2128-2138. PubMed ID: 32073096
[TBL] [Abstract][Full Text] [Related]
4. Polydopamine Coated PB-MnO
Odda AH; Li H; Kumar N; Ullah N; Khan MI; Wang G; Liang K; Liu T; Pan YY; Xu AW
Bioconjug Chem; 2020 May; 31(5):1474-1485. PubMed ID: 32286806
[TBL] [Abstract][Full Text] [Related]
5. Multifunctional theranostic nanosystems enabling photothermal-chemo combination therapy of triple-stimuli-responsive drug release with magnetic resonance imaging.
Lin X; Song X; Zhang Y; Cao Y; Xue Y; Wu F; Yu F; Wu M; Zhu X
Biomater Sci; 2020 Mar; 8(7):1875-1884. PubMed ID: 32010912
[TBL] [Abstract][Full Text] [Related]
6. Ce6-Modified Carbon Dots for Multimodal-Imaging-Guided and Single-NIR-Laser-Triggered Photothermal/Photodynamic Synergistic Cancer Therapy by Reduced Irradiation Power.
Sun S; Chen J; Jiang K; Tang Z; Wang Y; Li Z; Liu C; Wu A; Lin H
ACS Appl Mater Interfaces; 2019 Feb; 11(6):5791-5803. PubMed ID: 30648846
[TBL] [Abstract][Full Text] [Related]
7. Photosensitizer-conjugated Cu-In-S heterostructured nanorods for cancer targeted photothermal/photodynamic synergistic therapy.
Chen SH; Huang WW; Dehvari K; Ling YC; Ghule AV; Tsai SL; Chang JY
Mater Sci Eng C Mater Biol Appl; 2019 Apr; 97():793-802. PubMed ID: 30678970
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticulate photosensitizer decorated with hyaluronic acid for photodynamic/photothermal cancer targeting therapy.
Wang X; Ouyang X; Chen J; Hu Y; Sun X; Yu Z
Nanomedicine (Lond); 2019 Jan; 14(2):151-167. PubMed ID: 30511886
[TBL] [Abstract][Full Text] [Related]
9. Tumor microenvironment-responsive nanohybrid for hypoxia amelioration with photodynamic and near-infrared II photothermal combination therapy.
Zhang P; Wu Q; Yang J; Hou M; Zheng B; Xu J; Chai Y; Xiong L; Zhang C
Acta Biomater; 2022 Jul; 146():450-464. PubMed ID: 35526739
[TBL] [Abstract][Full Text] [Related]
10. Chlorin e6 Conjugated Poly(dopamine) Nanospheres as PDT/PTT Dual-Modal Therapeutic Agents for Enhanced Cancer Therapy.
Zhang D; Wu M; Zeng Y; Wu L; Wang Q; Han X; Liu X; Liu J
ACS Appl Mater Interfaces; 2015 Apr; 7(15):8176-87. PubMed ID: 25837008
[TBL] [Abstract][Full Text] [Related]
11. A Trojan horse biomimetic delivery strategy using mesenchymal stem cells for PDT/PTT therapy against lung melanoma metastasis.
Ouyang X; Wang X; Kraatz HB; Ahmadi S; Gao J; Lv Y; Sun X; Huang Y
Biomater Sci; 2020 Feb; 8(4):1160-1170. PubMed ID: 31848537
[TBL] [Abstract][Full Text] [Related]
12. CD44 Receptor-Mediated/Reactive Oxygen Species-Sensitive Delivery of Nanophotosensitizers against Cervical Cancer Cells.
Yoon J; Kim H; Jeong YI; Yang HS
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408970
[TBL] [Abstract][Full Text] [Related]
13. PSMA-targeted melanin-like nanoparticles as a multifunctional nanoplatform for prostate cancer theranostics.
Dai L; Shen G; Wang Y; Yang P; Wang H; Liu Z
J Mater Chem B; 2021 Jan; 9(4):1151-1161. PubMed ID: 33434248
[TBL] [Abstract][Full Text] [Related]
14. Targeted co-delivery of a photosensitizer and an antisense oligonucleotide based on an activatable hyaluronic acid nanosystem with endogenous oxygen generation for enhanced photodynamic therapy of hypoxic tumors.
Wu Y; Ding L; Zheng C; Li H; Wu M; Sun Y; Liu X; Zhang X; Zeng Y
Acta Biomater; 2022 Nov; 153():419-430. PubMed ID: 36115655
[TBL] [Abstract][Full Text] [Related]
15. A dual-targeted hyaluronic acid-gold nanorod platform with triple-stimuli responsiveness for photodynamic/photothermal therapy of breast cancer.
Xu W; Qian J; Hou G; Wang Y; Wang J; Sun T; Ji L; Suo A; Yao Y
Acta Biomater; 2019 Jan; 83():400-413. PubMed ID: 30465921
[TBL] [Abstract][Full Text] [Related]
16. Dual-Mode Imaging Guided Multifunctional Theranosomes with Mitochondria Targeting for Photothermally Controlled and Enhanced Photodynamic Therapy in Vitro and in Vivo.
Wang S; Guo F; Ji Y; Yu M; Wang J; Li N
Mol Pharm; 2018 Aug; 15(8):3318-3331. PubMed ID: 29975536
[TBL] [Abstract][Full Text] [Related]
17. Folic acid-modified Prussian blue/polydopamine nanoparticles as an MRI agent for use in targeted chemo/photothermal therapy.
Lin X; Cao Y; Li J; Zheng D; Lan S; Xue Y; Yu F; Wu M; Zhu X
Biomater Sci; 2019 Jul; 7(7):2996-3006. PubMed ID: 31111139
[TBL] [Abstract][Full Text] [Related]
18. Catalase-Integrated Hyaluronic Acid as Nanocarriers for Enhanced Photodynamic Therapy in Solid Tumor.
Phua SZF; Yang G; Lim WQ; Verma A; Chen H; Thanabalu T; Zhao Y
ACS Nano; 2019 Apr; 13(4):4742-4751. PubMed ID: 30964974
[TBL] [Abstract][Full Text] [Related]
19. PEG-functionalized iron oxide nanoclusters loaded with chlorin e6 for targeted, NIR light induced, photodynamic therapy.
Li Z; Wang C; Cheng L; Gong H; Yin S; Gong Q; Li Y; Liu Z
Biomaterials; 2013 Dec; 34(36):9160-70. PubMed ID: 24008045
[TBL] [Abstract][Full Text] [Related]
20. Tumor-specific activated photodynamic therapy with an oxidation-regulated strategy for enhancing anti-tumor efficacy.
Liang H; Zhou Z; Luo R; Sang M; Liu B; Sun M; Qu W; Feng F; Liu W
Theranostics; 2018; 8(18):5059-5071. PubMed ID: 30429886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
